Linezolid drug interactions: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Linezolid }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (..." |
No edit summary |
||
| Line 4: | Line 4: | ||
==DRUG INTERACTIONS== | |||
===Monoamine Oxidase Inhibitors=== | |||
Linezolid is a reversible, nonselective inhibitor of monoamine oxidase. [see Contraindications (4.2) and Clinical Pharmacology (12.3)]. | |||
===Adrenergic and Serotonergic Agents=== | |||
Linezolid has the potential for interaction with adrenergic and serotonergic agents. [see Warnings and Precautions (5.3, 5.6) and Clinical Pharmacology ]. | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd | publisher = | date = | accessdate = }}</ref> | <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd | publisher = | date = | accessdate = }}</ref> | ||
Latest revision as of 04:24, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
DRUG INTERACTIONS
Monoamine Oxidase Inhibitors
Linezolid is a reversible, nonselective inhibitor of monoamine oxidase. [see Contraindications (4.2) and Clinical Pharmacology (12.3)].
Adrenergic and Serotonergic Agents
Linezolid has the potential for interaction with adrenergic and serotonergic agents. [see Warnings and Precautions (5.3, 5.6) and Clinical Pharmacology ]. [1]
References
Adapted from the FDA Package Insert.